Opinion
3don MSNOpinion
Moves like these should be seen for what they are: power grabs from a president who appears indifferent to institutional limits and the rule of law.
1d
Pharmaceutical Technology on MSNEuropean agencies catch up with speedier regulatory pathways for CGTs in the USAlthough the regulatory landscape for advanced therapy medicinal products (ATMPs) is rapidly evolving, varying regulatory ...
President Donald Trump has removed the two Democratic commissioners from the U.S. Federal Trade Commission, a move that ...
The aerospace and defense industry is facing a rapidly shifting legal landscape in 2025, shaped by regulatory updates, enforcement trends, ...
That era is now ending. Loper Bright Enterprises v. Raimondo struck at the heart of Chevron, limiting agencies’ ability to ...
Exploring Regulatory Affairs, the discipline dedicated to ensuring that new drugs and biologics are safe, effective, and ...
The lawsuit against the issuer of the XRP coin claimed the token was an unregistered security. Now, the SEC is dropping the ...
On March 7, 2025, Health Canada’s Pest Management Regulatory Agency (PMRA) published two consultation documents as part of its ongoing work to clarify which categories of pest control products ...
Discover how outsourcing regulatory submission content development improves efficiency and ensures compliance.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results